Expression Profiling of a Human Thyroid Cell Line Stably Expressing the BRAFV600E Mutation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The BRAF^V600E mutation is a key driver in papillary thyroid carcinoma (PTC) initiation.
• Understanding gene expression changes induced by BRAF^V600E is crucial for thyroid cancer research.

Purpose of the Study:

• To investigate the genomic alterations and molecular consequences of the BRAF^V600E mutation in thyroid cancer.
• To establish and characterize human thyroid cell lines expressing wild-type (Nthy/WT) and V600E mutant BRAF (Nthy/V600E).

Main Methods:

• Stable transfection of BRAF genes into human thyroid cell lines.
• Functional assays including anchorage-independent growth and Matrigel invasion.
• Microarray analysis for gene expression profiling and Gene Ontology/pathway analysis.

Main Results:

• Stable BRAF gene transfection confirmed by flow cytometry and western blotting.
• Nthy/V600E cells exhibited significantly increased anchorage-independent growth and invasion compared to Nthy/WT cells.
• Microarray analysis identified 2,441 upregulated genes in Nthy/V600E cells, associated with cell adhesion, migration, ERK/MAPK signaling, and cancer pathways.

Conclusions:

• The developed Nthy/WT and Nthy/V600E cell line pair serves as a valuable model for studying BRAF^V600E-driven PTC.
• This model facilitates research into the molecular mechanisms underlying BRAF^V600E-associated thyroid cancer progression.